Chris Boshoff
President at SEAGEN INC.
Net worth: 4 M $ as of 2024-05-30
Profile
Dr. Chris Boshoff is a President at Seagen Inc., a Chief Oncology Officer & Executive Vice President at Pfizer Inc. and a Vice President-Translational Oncology at Pfizer (La Jolla).
Dr. Boshoff was previously employed as a Non-Executive Director by Advanced Oncotherapy Plc.
He received his doctorate degree from the University of Pretoria.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PFIZER INC.
0.00% | 2024-02-27 | 156,631 ( 0.00% ) | 4 M $ | 2024-05-30 |
Chris Boshoff active positions
| Companies | Position | Start |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 2023-07-26 |
| SEAGEN INC. | President | 2023-12-13 |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer (La Jolla) is a company that provides research services. The company is based in San Diego, CA. The company was founded by Michael R. Jirousek. | Corporate Officer/Principal | - |
Former positions of Chris Boshoff
| Companies | Position | End |
|---|---|---|
| ADVANCED ONCOTHERAPY PLC | Director/Board Member | 2013-10-24 |
Training of Chris Boshoff
| University of Pretoria | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ADVANCED ONCOTHERAPY PLC | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Pfizer (La Jolla)
Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer (La Jolla) is a company that provides research services. The company is based in San Diego, CA. The company was founded by Michael R. Jirousek. | Commercial Services |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- Chris Boshoff
